Pharma Focus Asia

Amgen Invests US$325 million to Construct New Plant in Central Ohio


Amgen plans to construct new biomanufacturing plant. The new plant will support the increasing demand for Amgen's medicines in the United States.


The new state-of-the-art manufacturing facility, enables to bring new innovative medicines for patients.

This cutting edge facility will be used by 400 ohioans for package medicines and benefit millions of people’s life those battling with serious illnesses. Moreover, environmental sustainability will be a major priority and it also ensures to maximise energy efficiency and waste reduction, plans to make operations carbon neutral over the next several years.

After the completion of the project, it will provide new job opportunities for technicians and engineers, along with quality assurance, quality control, administrative and management positions.

The construction of the new facility is expected to be fully operational by 2024.


TypeNew Construction
BudgetUS$325 million
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Asia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024
Charles river - Endosafe Trillium